Shrem Zilberman Group

Shrem Zilberman Group is an Israeli-based investment and holding firm that specializes in the life sciences, medical technology, and biotechnology sectors. Led by veteran financiers Itzhak Shrem and Avi Zilberman, the group focuses on identifying high-potential healthcare startups and facilitating their growth through strategic management, capital injection, and public market listings. The group is well-known for its expertise in corporate restructuring and utilizing public shells to bring innovative medical technologies to the Tel Aviv Stock Exchange and NASDAQ. Their portfolio has historically included diverse interests in areas such as immunotherapy, neurostimulation, and advanced medical diagnostics. By providing both financial backing and board-level leadership, Shrem Zilberman Group plays a significant role in the Israeli biotech ecosystem.